Progyny, Inc. Deferred Costs, Noncurrent
Progyny, Inc. (PGNY) had Deferred Costs, Noncurrent of $2.70 million as of 2019-09-30, per its 10-Q filed 2019-12-06.
Discontinued › Balance Sheet › Assets
us-gaap:DeferredCosts · last filed 2019-12-06
- 2019-09-30: Deferred Costs, Noncurrent $2.70M.
- 2018-12-31: Deferred Costs, Noncurrent $0.00.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2019-09-30 | $2.70M 10-Q · filed 2019-12-06 |
| 2018-12-31 | $0.00 10-Q · filed 2019-12-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |